Entera Bio Issues Letter to Shareholders

BOSTON and JERUSALEM, Jan. 11, 2021 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, today issued a Letter to Shareholders from Spiros [...] Read more »